No Data
Jiangsu Apon Medical Technology (300753.SZ): The company has officially joined the "brain-computer interface industry alliance" as one of its members.
Gelonghui, November 4th, jiangsu apon medical technology (300753.SZ) stated on the investor interaction platform that it will participate in the Second Brain-Computer Interface Conference and the Fourth Brain-Computer Interface Industry Alliance Conference, which will be held in wuhan, hubei on November 16th to 17th. The company has been invited to attend and has officially joined the "Brain-Computer Interface Industry Alliance" as one of its members. This conference, themed 'Brain-Machine Interconnection, Creating the Future Together,' aims to strengthen the exchange and cooperation between brain-computer interface technology and industry, discussing the future development of the brain-computer interface industry.
Aibang Healthcare: Third Quarter 2024 Report
Jiangsu Apon Medical Technology (300753.SZ): The net income in the first three quarters was 3.8073 million yuan, a year-on-year decrease of 43.99%.
On October 29, Gelonhui reported that Jiangsu Apon Medical Technology (300753.SZ) released its third quarter report for 2024, achieving revenue of 0.275 billion yuan in the first three quarters, down 7.12% year-on-year; net income attributable to shareholders of the listed company was 3.8073 million yuan, down 43.99% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.8721 million yuan, down 74.25% year-on-year; basic earnings per share was 0.0302 yuan.
Jiangsu Apon Medical Technology (300753.SZ): Currently, it has implemented new features in the field of EEG anesthesia depth algorithm, such as EEG time-frequency analysis technology and intraoperative brain aging assessment based on intraoperative EEG ch
Geelonghui October 21st, jiangsu apon medical technology (300753.SZ) stated on the investor interaction platform that the brain-computer interface system is mainly composed of the user (brain), brain signal acquisition, brain signal processing, controlling external devices, and neural feedback. The company's anesthetic depth monitor product belongs to the EEG acquisition equipment, using non-invasive electrodes to collect EEG signals, which are then processed and applied in the field of anesthetic depth monitoring. Currently, the company has implemented new functions in EEG anesthetic depth algorithms, such as EEG time-frequency analysis technology and brain aging assessment based on intraoperative EEG features.
Jiangsu Apon Medical Technology (300753.SZ): Currently, they have established cooperation with several well-known private hospitals such as Peking United Family Hospital and Taikang Hospital.
Jiangsu Apon Medical Technology (300753.SZ) stated on the investor interaction platform on September 12 that the company's main business includes pain management and nasal and upper airway management, and it has established private hospital channels, including but not limited to pain pumps, anesthesia depth monitors, nasal care sprays, fixed snoring devices, and medical beauty products. It has already established cooperation with several well-known private hospitals such as Peking United Family Hospital and Taikang Hospital.
Jiangsu Apon Medical Technology (SZSE:300753) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Not Doing Enough For Some Investors As Its Shares Slump 25%No Data
No Data
